Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the journal Alzheimer’s & Dementia.
Read more at NBC News
-
Ozempic lowers Alzheimer’s risk: Research
Politics - The Hill - October 24 -
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Business - CNBC - October 24 -
Sugar Rationing Lowered Diabetes and Hypertension in British Children
Health - The New York Times - October 31 -
Ozempic and Wegovy considered 'available' after more than 2 years in shortage
Politics - The Hill - October 30 -
Elon Musk is hiring for DOGE. Here's the type of people he wants to recruit
Politics - The Hill - 5 days ago -
Just 5 minutes of this type of exercise could help lower blood pressure, study suggests
Top stories - NBC News - November 7 -
More than 800 million people around the world have diabetes, study finds
World - The Guardian - November 13 -
Insta360 Link 2 Review: A Cheaper, Better Webcam
Tech - Wired - 2 days ago
More from NBC News
-
Trump taps Scott Bessent to serve as treasury secretary
Top stories - NBC News - 8 hours ago -
Trump picks Project 2025 co-author Russell Vought to lead budget office
Top stories - NBC News - 4 hours ago -
Trump's mass deportations could split 4 million families. How one is getting ready.
Top stories - NBC News - 4 hours ago -
Vaccines don't cause autism. What does?
Top stories - NBC News - 11 hours ago -
Researchers capture baleen whales for the first time to study their hearing
Top stories - NBC News - 8 hours ago